Pyrazole-based sulfonamide and sulfamides as potent inhibitors of mammalian 15-lipoxygenase

被引：30
|
作者：
Ngu, Khehyong [1 ]
Weinstein, David S. [1 ]
Liu, Wen [1 ]
Langevine, Charles [1 ]
Combs, Donald W. [1 ]
Zhuang, Shaobin [1 ]
Chen, Xing [1 ]
Madsen, Cort S. [1 ]
Harper, Timothy W. [1 ]
Ahmad, Saleem [1 ]
Robl, Jeffrey A. [1 ]
机构：
[1] Bristol Myers Squibb Co, Res & Dev, Princeton, NJ 08543 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 14期
关键词：
15-Lipoxygenase; Inhibitors; Pyrazole; Sulfonamides; Sulfamides; Arachidonic acid; Linoleic acid; LIPOXYGENASE INHIBITORS; SELECTIVE INHIBITORS; CANCER CELLS; 12-LIPOXYGENASE; 12/15-LIPOXYGENASE; DERIVATIVES; DISCOVERY; DISEASE; DESIGN; ENZYME;
D O I：
10.1016/j.bmcl.2011.05.107
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of inhibitors of mammalian 15-lipoxygenase (15-LO) based on a 3,4,5-tri-substituted pyrazole scaffold is described. Replacement of a sulfonamide functionality in the lead series with a sulfamide group resulted in improved physicochemical properties generating analogs with enhanced inhibition in cell-based and whole blood assays. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4141 / 4145
页数：5
相关论文
共 50 条
  • [31] Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β
    Tan, Kathrin
    Jaeger, Christian
    Geissler, Stefanie
    Schlenzig, Dagmar
    Buchholz, Mirko
    Ramsbeck, Daniel
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [32] Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: Optimization of cellular potency
    Ameriks, Michael K.
    Cai, Hui
    Edwards, James P.
    Gebauer, Damara
    Gleason, Elizabeth
    Gu, Yin
    Karlsson, Lars
    Nguyen, Steven
    Sun, Siquan
    Thurmond, Robin L.
    Zhu, Jian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6135 - 6139
  • [33] Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors
    Mahdavi, Mohammad
    Shirazi, Maryam Shahzad
    Taherkhani, Raana
    Saeedi, Mina
    Alipour, Eskandar
    Moghadam, Farshad Homayouni
    Moradi, Alireza
    Nadri, Hamid
    Emami, Saeed
    Firoozpour, Loghman
    Shafiee, Abbas
    Foroumadi, Alireza
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 82 : 308 - 313
  • [34] Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase
    Tehrani, Maliheh Barazandeh
    Emami, Saeed
    Asadi, Mehdi
    Saeedi, Mina
    Mirzahekmati, Mohammadreza
    Ebrahimi, Seyyed Mostafa
    Mahdavi, Mohammad
    Nadri, Hamid
    Moradi, Alireza
    Moghadam, Farshad Homayouni
    Farzipour, Soghra
    Vosooghi, Mohsen
    Foroumadi, Alireza
    Shafiee, Abbas
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 87 : 759 - 764
  • [35] 6-substituted purines as inhibitors of 15-lipoxygenase;: a structure-activity study
    Bråthe, A
    Gundersen, LL
    Malterud, KE
    Rise, F
    ARCHIV DER PHARMAZIE, 2005, 338 (04) : 159 - 166
  • [36] Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors
    Ameriks, Michael K.
    Bembenek, Scott D.
    Burdett, Matthew T.
    Choong, Ingrid C.
    Edwards, James P.
    Gebauer, Damara
    Gu, Yin
    Karlsson, Lars
    Purkey, Hans E.
    Staker, Bart L.
    Sun, Siquan
    Thurmond, Robin L.
    Zhu, Jian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (14) : 4060 - 4064
  • [37] Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase
    da Silva, EL
    Abdalla, DSP
    Terao, J
    IUBMB LIFE, 2000, 49 (04) : 289 - 295
  • [38] Pyrazole-Based Lactate Dehydrogenase Inhibitors with Optimized Cell Activity and Pharmacokinetic Properties
    Rai, Ganesha
    Urban, Daniel J.
    Mott, Bryan T.
    Hu, Xin
    Yang, Shyh-Ming
    Benavides, Gloria A.
    Johnson, Michelle S.
    Squadrito, Giuseppe L.
    Brimacombe, Kyle R.
    Lee, Tobie D.
    Cheff, Dorian M.
    Zhu, Hu
    Henderson, Mark J.
    Pohida, Katherine
    Sulikowski, Gary A.
    Dranow, David M.
    Kabir, Md
    Shah, Pranav
    Padilha, Elias
    Tao, Dingyin
    Fang, Yuhong
    Christov, Plamen P.
    Kim, Kwangho
    Jana, Somnath
    Muttil, Pavan
    Anderson, Tamara
    Kunda, Nitesh K.
    Hathaway, Helen J.
    Kusewitt, Donna F.
    Oshima, Nobu
    Cherukuri, Murali
    Davies, Douglas R.
    Norenberg, Jeffrey P.
    Sklar, Larry A.
    Moore, William J.
    Dang, Chi, V
    Stott, Gordon M.
    Neckers, Leonard
    Flint, Andrew J.
    Darley-Usmar, Victor M.
    Simeonov, Anton
    Waterson, Alex G.
    Jadhav, Ajit
    Hall, Matthew D.
    Maloney, David J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 10984 - 11011
  • [39] Comparison of eight 15-lipoxygenase (LO) inhibitors on the biosynthesis of 15-LO metabolites by human neutrophils and eosinophils
    Archambault, Anne-Sophie
    Turcotte, Caroline
    Martin, Cyril
    Provost, Veronique
    Larose, Marie-Chantal
    Laprise, Catherine
    Chakir, Jamila
    Bissonnette, Elyse
    Laviolette, Michel
    Bosse, Ynuk
    Flamand, Nicolas
    PLOS ONE, 2018, 13 (08):
  • [40] Lipoxygenase inhibitors from natural plant sources. Part 2: Medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists
    Schneider, I
    Bucar, F
    PHYTOTHERAPY RESEARCH, 2005, 19 (04) : 263 - 272
12345